NCT03250741View on ClinicalTrials.gov

Effects of Dopaminergic Therapy in Patients With Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Alzheimer Disease
Interventions
DRUG

Rotigotine transdermal patch

Rotigotine transdermal patches 4mg/24hr

OTHER

Placebo

Placebo transdermal patches of the same size as for Rotigotine transdermal patches

Trial Locations (1)

00179

Santa Lucia Foundation, Rome

All Listed Sponsors
lead

I.R.C.C.S. Fondazione Santa Lucia

OTHER

NCT03250741 - Effects of Dopaminergic Therapy in Patients With Alzheimer's Disease | Biotech Hunter | Biotech Hunter